期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

透析患者营养不良的干预方式 被引量：1

Intervention methods for dialysis patients with malnutrition
原文传递
导出
摘要 随着透析人群的扩大,透析手段的进步,老年透析患者的增加,营养不良逐渐成为影响透析质量的重要因素。本文结合文献及笔者的研究,对透析患者营养不良的原因进行了较全面的分析,同时归纳总结了目前对透析营养不良患者,进行透析相关与非透析相关治疗的方法 ,强调综合多方面的手段和策略,针对不同人群制定个性化的治疗方案为最佳选择。 Malnutrition has gradually become an important factor affecting the quality of dialysis patients with the expansion of dialysis population, dialysis means＇ progress, and the increase of elderly patients. This paper analyzed the causes of malnutrition in dialysis patients, summarized both dialysis- related and non-dialysis-related methods of current treatment for malnutrition in dialysis patients, emphasizing that it is the best choice to develop individualized treatment plans for different populations with multi-disciplinary means and strategies.
作者 郭志勇 赖学莉
机构地区 第二军医大学长海医院肾内科
出处 《中华肾病研究电子杂志》 2015年第3期28-31,共4页 Chinese Journal of Kidney Disease Investigation（Electronic Edition）
关键词 透析 营养不良 治疗 Dialysis Malnutrition Treatment
分类号 R459.5 [医药卫生—治疗学]
  • 相关文献

参考文献19

  • 1Genctoy G, Arikan S, Eldem O. Pulmonary hypertension associates with malnutrition and body composition hemodialysis patients [ J ]. Ren Fail, 2014, 37(2) : 273-279.
  • 2Stenvinkel P, Heimburger O, Lindholm B, et al. Are there two types of malnutrition in chronic renal failure.'? Evidence for relationships between malnutrition, inflammation and atherosclerosis ( MIA syndrome) [ J ]. Nephrol Dial Transplant, 2000, 15 ( 7 ) : 953-960.
  • 3Alwakeel JS, Usama S, Mitwalli AH, et al. Prevalence of vitamin D deficiency in peritoneal dialysis patients [ J ]. Saudi J Kidney Dis Transpl, 2014, 25(5): 981-985.
  • 4lwasaki Y, Yamato H, Nii-Kono T, et al. Uremic toxin and bone metabolism [J~. J Bone Miner Metab, 2006, 24(2): 172-175.
  • 5Tanaka S, Yano S, Sheikh AM, et al. Effects of uremic toxin p- cresol on proliferation, apoptosis, differentiation, and glucose uptake in 3T3-L1 cells [J]. Artif Organs, 2014, 38(7): 566-571.
  • 6Bossola M, Muscaritoli M, Tazza L, et al. Malnutrition in hemodialysis patients: what therapy [ J~. Am J Kidney Dis, 2005, 46(3) : 371-386.
  • 7Guarnieri G, Barazzoni R. Fighting protein-energy wasting in chronic kidney disease: a challenge of complexity [ J]. J Ren Nutr, 2011, 21(1): 2-6.
  • 8赖学莉,邱秋,谌卫,郭志勇,蔡莉莉,徐海燕.总剂量注射低分子右旋糖酐铁对腹膜透析患者贫血及微炎症的影响[J].第二军医大学学报,2009,30(9):1081-1083. 被引量：2
  • 9Sirich TL, Plummer NS, Gardner CD, et al. Effect of increasingdietary fiber on plasma levels of colon- derived solutes in hemodialysis patients [J]. Clin J Am Soc Nephrol, 2014, 9(9) : 1603-1610.
  • 10Kopple JD, Cheung AK, Chtistiansen JS, et al. OPPORTUNITyTM : a large-scale randomized clinical trial of growth hormone in hemodialysis patients [ J ]. Nephrol Dial Transplant, 2011, 26(12): 4095-4103.

二级参考文献11

  • 1Dahdah K, Patrie J T, Bolton W K. Intravenous iron dextran treatment in predialysis patients with chronic renal failure[J]. Am J Kidney Dis,2000,36:775 -782.
  • 2Chugh S N,Jain S,Agrawal N,Sharma A. Evaluation of oxidative stress before and after haemodialysis in chronic renal failure[J]. J Assoc Physicians India,2000,48:981- 984.
  • 3KDOQI. KDOQI clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease: 2007 up- date of hemoglobin target[J]. Am J Kidney Dis, 2007,50:471- 530.
  • 4Bhandari S, Naudeer S. Improving efficiency and value in health care. Intravenous iron management for anaemia associated with chronic kidney disease:linking treatment to an outpatient clinic, optimizing service provision and patient choice[J]. J Eval Clin Pract, 2008,14 : 996-1001.
  • 5Blaustein D A,Schwenk M H,Chattopadhyay J, Avram M M. Recent experience with high-dose intravenous iron administration[J]. Kidney Int, 2006,70:S26-S29.
  • 6Bergstrom J, Lindholm B, Lacson E Jr, Owen W Jr, Lowrie E G,Glassock R J,et al. What are the causes and consequences of the chronic inflammatory state in chronic dialysis patients[J]. Semin Dial, 2000,13 :163-175.
  • 7Kuo K L,Hung S C,Wei Y H,Tarng D C. Intravenous iron ex acerbates oxidative DNA damage in peripheral blood lympho cytes in chronic hemodialysis patients[J]. J Am Soc Nephrol 2008,19:1817-1826.
  • 8Pai A B,Boyd A V,McQuade C R,Harford A,Norenberg J P, Zager P G. Comparison of oxidative stress markers after intra venous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis[J]. Phar macot herapy, 2007,27 : 343-350.
  • 9Li H,Wang S X. Intravenous iron sucrose in peritoneal dialysis patients with renal anemia[J]. Perit Dial Int,2008,28:149- 154.
  • 10Weiss G, Meusburger E, Radacher G, Garimorth K, Neyer U, Mayer G. Effect of iron treatment on circulating cytokine levels in ESRD patients receiving recombinant human erythropoietin [J]. Kidney Int,2003,64:572-578.

共引文献1

同被引文献1

引证文献1

中华肾病研究电子杂志
2015年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部